ArticleFrontiers in nephrology2022

Outcomes from the Northeast England cohort of autosomal dominant polycystic kidney disease (ADPKD) patients on tolvaptan.

Eleftherios Gkekas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.